
In comparison to the RECIST 1.1 criteria, use of the mpMRI-based NacBI-RADS system for evaluating response to neoadjuvant chemotherapy (NAC) for breast cancer offered an 8 percent higher sensitivity and over 26 percent higher specificity.
49-year-old patient presented for bilateral screening mammogram as well as bilateral screening ultrasound due to dense breast tissue.
49-year-old patient presented for a bilateral screening mammogram as well as a bilateral screening ultrasound due to dense breast tissue. On mammography, dense breast tissue was noted and no suspicious masses or calcification were seen in either breast.
What's your diagnosis?



